Elite Pharmaceuticals, Inc.

Common Stock SEC Reporting - Current
Contact Info
  • 165 Ludlow Avenue
  • Northvale, NJ 07647

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0001053369
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: NV, USA
Year of Inc. 1990
Employees 48 a/o Feb 01, 2017
Company Officers/Contacts
Nasrat Hakim CEO, President, Other
Carter J. Ward CFO, Secretary, Treasurer
Company Directors
Nasrat Hakim Chairman
David S. Caskey
Barry Dash
Eugene M. Pfeifer
Jeffrey Whitnell
Service Providers
Accounting/Auditing Firm
Buchbinder Tunick & Company LLP
155 US Highway 46
Wayne, NJ, 07470
United States
Securities Counsel

Not Available
Investor Relations Firm

Not Available
ELTP Security Details
Share Structure
Market Value1 $131,259,477 a/o Feb 17, 2017
Authorized Shares 995,000,000 a/o Nov 04, 2016
Outstanding Shares 917,898,440 a/o Feb 01, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 593,924,695 a/o Jun 07, 2016
Par Value 0.01
Transfer Agent(s) Verified by Transfer Agent
American Stock Transfer & Trust Company
Shareholders of Record 136 a/o Jun 15, 2016
Short Selling Data
Short Interest 33,533 (-51.76%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security